Search
forResearch 10 of 1000+
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Molecular Mechanisms and Targeted Therapeutics in Androgenetic Alopecia: From Signaling Pathways to Regenerative Approaches
- Therapeutic potential of Ishophloroglucin a from Ishige okamurae in androgenic alopecia: inhibition of 5α-reductase activity and activation of the Wnt/β-catenin signaling pathway in human dermal papilla cells
- Therapeutic Effects of Modified Changfa Zirong Powder on Androgenetic Alopecia through the Wnt/β-Catenin Signaling Pathway
- Therapeutic potential of isoproterenol in androgenetic alopecia: activation of hair follicle stem cells via the PI3K/AKT/β-Catenin signaling pathway
- Androgenetic alopecia: combing the hair follicle signaling pathways for new therapeutic targets and more effective treatment options
- Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers
- iTRAQ-based quantitative proteomics revealing the therapeutic mechanism of a medicinal and edible formula YH0618 in reducing doxorubicin-induced alopecia by targeting keratins and TGF-β/Smad3 pathway
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways
Community 7 of 15
- Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases
- mallia therapeutics 8T3 scd83 molecule for ffa/lpp mainly and aga
- The Chinese version of Stemson Therapeutics (Hair Multiplication) is here. It is called Yunce Medical.
- Eirion Therapeutics Announces Potential Breakthrough Treatment for Hair Loss Based on First-in-Man Clinical Trial Results
- Horrible news, Stemson Therapeutics has shut down
- Stemson Therapeutics Announces Technological Breakthrough in new Hair Growth
- IGFBP‐rP1 is a potential therapeutic target in androgenic alopecia